Intranasal flu vaccines: Not to be sniffed at

作者: Mark Greener

DOI: 10.12968/BJSN.2015.10.4.168

关键词:

摘要: The universal childhood programme using intranasal influenza vaccine started in 2013-2014. In addition to preventing symptoms and complications, the nasal flu reduces virus's spread other people. Clinical studies have found that prevents a high number of infections it appears be more effective than injectable vaccine. Nasal congestion rhinorrhoea seem most common adverse reactions. Although seems well tolerated, nurses should report any suspected side effects. School continue underscore importance good hygiene further reduce risk transmission.

参考文章(3)
Daniel B. Hawcutt, Pramod Mainie, Andrew Riordan, Rosalind L. Smyth, Munir Pirmohamed, Reported paediatric adverse drug reactions in the UK 2000–2009 British Journal of Clinical Pharmacology. ,vol. 73, pp. 437- 446 ,(2012) , 10.1111/J.1365-2125.2011.04113.X
Andrew C Hayward, Ellen B Fragaszy, Alison Bermingham, Lili Wang, Andrew Copas, W John Edmunds, Neil Ferguson, Nilu Goonetilleke, Gabrielle Harvey, Jana Kovar, Megan SC Lim, Andrew McMichael, Elizabeth RC Millett, Jonathan S Nguyen-Van-Tam, Irwin Nazareth, Richard Pebody, Faiza Tabassum, John M Watson, Fatima B Wurie, Anne M Johnson, Maria Zambon, None, Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study The Lancet Respiratory Medicine. ,vol. 2, pp. 445- 454 ,(2014) , 10.1016/S2213-2600(14)70034-7